Blood tests for infection in newborns
Part of Genetic & congenital, Infections clinical trials.
This study looks at how blood markers like lactate and complete blood count (CBC) can help spot infection in newborns up to 28 days old. It may lead to faster, more accurate diagnosis for babies with possible sepsis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Newborn between 0 and 28 days old (born at any stage, full-term or premature)
- Has at least 2 signs that could mean sepsis (like fever, fast or slow heart rate, trouble feeding, drowsiness, or floppy muscles)
- Parent or guardian agrees in writing to let the baby take part
- Does NOT have severe birth defects or chromosomal problems
- Has NOT already had strong antibiotics for more than a day before joining
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new blood test (called presepsin) to see if it can help doctors quickly diagnose sepsis (a serious infection) in newborns. If your baby has signs of infection, this test might help find the cause sooner.
This trial tests a new, faster way to find bacteria in the blood of children with suspected sepsis. It uses a molecular test that may give results sooner than standard cultures, helping doctors treat infections more quickly.
This study looks at early signs of infection in premature babies. It checks two substances in the baby's blood (IL-6 and PCT) within the first 12 hours after birth to see if they can help detect sepsis early. Participation involves collecting a small extra blood sample during routine tests.
This study looks at a specific blood protein level in children from birth to age 17. It compares healthy children and those with sepsis to see if the protein changes during infection.
This trial tests a new biomarker (T6A) to detect bacterial infections in newborn babies. It aims to help doctors diagnose infections faster and more accurately.
This study compares two blood test measurements (neutrophil/lymphocyte ratio and lactate/albumin ratio) to see which better predicts how severe an infection is in ICU patients with sepsis. It aims to find a simpler way to track inflammation.
Hear when a new Neonatal Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.